May 22, 2015 Dear client-partners, I am pleased to announce two exciting developments that will help further distinguish us as a leading global pharma services company. As of today, Tanner Pharmaceuticals and BurnsAdler Pharmaceuticals have merged to form Tanner Pharma Group. Due to this exciting announcement, we have decided to forego publishing this week's Healthcare and Pharmaceutical M&A Newsletter; however, trading comps and transaction tablesare available by clicking the respective links. This will only be a one-time interruption. The new Tanner Pharma Group will provide an enhanced service offering and increased global reach, while maintaining the high level of expertise and customer service that you have come to expect from both Tanner and BurnsAdler. Tanner Pharma Group is now comprised of three complementary divisions: Tanner Clinical Trial Sourcing (TannerCTS); Tanner Global Access Programmes (TannerGAP); and Tanner Licensing, Acquisition and Commercialization (Tanner- LAC). This new structural alignment will allow us to offer highly specialized services to our partners while leveraging our experience and standards of quality across the entire platform. This merger also signifies the start of the next phase of our Global Growth Strategy which includes the opening of a new office in London, joining offices in Sao Paulo and Mexico City as our third international hub. The London office will oversee business development and operations for UK/EU opportunities within the TannerCTS and TannerGAP divisions. At Tanner Pharma Group, our core purpose remains to improve lives by building meaningful and mutually beneficial relationships with healthcare professionals who share this commitment. Thank you for your continued confidence in Tanner Pharma Group as we work together to provide access to life-changing treatments across the globe. To learn more about the new Tanner Pharma Group, visit www.TannerPharma.com. Sincerely, Banks Bourne Chief Executive Officer Bourne Partners

TannerCTS TannerCTS procures comparator products for manufacturers, CROs and research centers from a broad range of sources. Additionally, the company provides clinical trial logistics and inventory management for trials conducted in the U.S., Europe, Mexico and Brazil. TannerGAP TannerGAP serves manufacturers and providers by developing, implementing and managing Global Access Programmes in international markets. Our experience includes Named Patient Programmes, Expanded Access Programmes, Compassionate Use Programmes and Emergency Supply allocations. TannerLAC TannerLAC serves pharmaceutical, biotech and healthcare companies by maximizing commercial potential for their products in Latin America and other international markets. Our licensing and registration model minimizes the risk, investment and resources necessary for companies to achieve their revenue goals in international markets. Tanner Pharma Group 1808 Associates Lane Charlotte, North Carolina 28217 United States Phone: +1704-552-8408